CAPITAL FUND MANAGEMENT S.A.

Position in IONS — Ionis Pharmaceuticals Inc

CIK 1323645 PARIS, I0

Position in IONS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$26,130,336

+$15,452,463 QoQ

Shares Held

329,554

+131.8% QoQ

Ownership

0.198%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#70

of 513 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

CAPITAL FUND MANAGEMENT S.A. holds $326,278,392 across 42 Biotechnology names. IONS ranks #5 (8.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	155,904	$46,931,781
2	INCY	Incyte Corp	336,318	$38,125,008
3	VRTX	Vertex Pharmaceuticals Inc / Ma	71,088	$35,311,542
4	EXEL	Exelixis, Inc.	527,235	$28,686,856
5	IONS	Ionis Pharmaceuticals Inc This page	329,554	$26,130,336
6	MRNA	Moderna, Inc.	277,758	$19,451,392
7	CORT	Corcept Therapeutics Inc	184,231	$16,018,885
8	INSM	INSMED Inc	148,976	$15,883,821

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$26,130,336	329,554	+131.8%	Shares	Sole	2026-08-13
2026-03-31	$10,677,873	142,201	+355.5%	Shares	Sole	2026-05-14
2025-06-30	$1,233,462	31,219	-46.2%	Shares	Sole	2025-08-13
2025-03-31	$1,750,282	58,014	+89.0%	Shares	Sole	2025-05-14
2024-09-30	$1,229,481	30,691	+171.3%	Shares	Sole	2024-11-13
2023-03-31	$404,362	11,314	-50.9%	Shares	Sole	2023-05-15
2022-09-30	$1,018,307	23,023	-41.1%	Shares	Sole	2022-11-14
2022-06-30	$1,447,852	39,110	-12.5%	Shares	Sole	2022-08-12
2022-03-31	$1,656,391	44,719	+59.1%	Shares	Sole	2022-05-12
2021-12-31	$855,326	28,108	+18.2%	Shares	Sole	2022-02-10
2020-09-30	$1,128,503	23,783	-28.2%	Shares	Sole	2020-11-13
2020-03-31	$1,565,488	33,111	—	Shares	Sole	2020-05-13
No filing history on record for this holder in this stock.